Spero Therapeutics Aktie
0,57
EUR
-0,07
EUR
-11,20
%
0,64
USD
-0,07
USD
-9,92
%
Werbung
Spero Therapeutics Aktie Analyse
09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung